Compare · PMI vs WST
PMI vs WST
Side-by-side comparison of Picard Medical Inc. (PMI) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PMI and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- WST is the larger of the two at $25.27B, about 1757.4x PMI ($14.4M).
- Over the past year, PMI is down 96.9% and WST is up 61.9% - WST leads by 158.8 points.
- PMI has been more active in the news (12 items in the past 4 weeks vs 5 for WST).
- WST has more recent analyst coverage (18 ratings vs 1 for PMI).
- Company
- Picard Medical Inc.
- West Pharmaceutical Services Inc.
- Price
- $0.15+3.43%
- $358.22-0.42%
- Market cap
- $14.4M
- $25.27B
- 1M return
- -17.98%
- +8.40%
- 1Y return
- -96.87%
- +61.91%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- AMEX
- NYSE
- IPO
- 2025
- News (4w)
- 12
- 5
- Recent ratings
- 1
- 18
West Pharmaceutical Services Inc.
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Latest PMI
- Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
- Amendment: Picard Medical Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Other Events
- SEC Form DEFA14A filed by Picard Medical Inc.
- SEC Form 425 filed by Picard Medical Inc.
- Picard Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 425 filed by Picard Medical Inc.
- Picard Medical Inc. filed SEC Form 8-K: Financial Statements and Exhibits
- Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
- Picard Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Picard Medical Inc.
Latest WST
- West Pharmaceutical Services Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- BNP Paribas Exane initiated coverage on West Pharm with a new price target
- West to Host Second-Quarter 2026 Conference Call
- SEC Form 4 filed by Director Haugen Janet Brutschea
- West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System
- West Pharm upgraded by Barclays with a new price target
- Wolfe Research resumed coverage on West Pharm with a new price target
- West Pharmaceutical Services Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- West Appoints Michel Lagarde to be President and Chief Executive Officer
- Amendment: West Pharmaceutical Services Inc. filed SEC Form 8-K: Financial Statements and Exhibits